Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial
Publication
, Conference
Pol, T; Hijazi, Z; Alexander, JH; Alings, M; Erol, C; Granger, CB; Goto, S; Halvorsen, S; Held, C; Huber, K; Hanna, M; Lopes, RD; Ruzyllo, W ...
Published in: EUROPEAN HEART JOURNAL
August 1, 2017
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2017
Volume
38
Start / End Page
760 / 761
Publisher
OXFORD UNIV PRESS
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Pol, T., Hijazi, Z., Alexander, J. H., Alings, M., Erol, C., Granger, C. B., … Wallentin, L. (2017). Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial. In EUROPEAN HEART JOURNAL (Vol. 38, pp. 760–761). OXFORD UNIV PRESS.
Pol, T., Z. Hijazi, J. H. Alexander, M. Alings, C. Erol, C. B. Granger, S. Goto, et al. “Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial.” In EUROPEAN HEART JOURNAL, 38:760–61. OXFORD UNIV PRESS, 2017.
Pol T, Hijazi Z, Alexander JH, Alings M, Erol C, Granger CB, et al. Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2017. p. 760–1.
Pol, T., et al. “Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial.” EUROPEAN HEART JOURNAL, vol. 38, OXFORD UNIV PRESS, 2017, pp. 760–61.
Pol T, Hijazi Z, Alexander JH, Alings M, Erol C, Granger CB, Goto S, Halvorsen S, Held C, Huber K, Hanna M, Lopes RD, Ruzyllo W, Siegbahn A, Wallentin L. Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2017. p. 760–761.
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2017
Volume
38
Start / End Page
760 / 761
Publisher
OXFORD UNIV PRESS
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology